ARHGEF9: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
[[Category:Signal transduction]] | [[Category:Signal transduction]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:07, 17 March 2025
ARHGEF9[edit]
ARHGEF9 (Rho guanine nucleotide exchange factor 9) is a protein-coding gene in humans that plays a crucial role in the regulation of the Rho family of GTPases, which are involved in various cellular processes including cytoskeletal organization, cell migration, and synaptic function. The ARHGEF9 gene is located on chromosome Xq11.1 and encodes a protein known as collybistin.
Function[edit]
ARHGEF9 is primarily expressed in the brain and is involved in the formation and maintenance of inhibitory synapses. The protein collybistin, encoded by ARHGEF9, interacts with the postsynaptic scaffolding protein gephyrin, which is essential for the clustering of GABA and glycine receptors at inhibitory synapses. This interaction is critical for the proper functioning of inhibitory neurotransmission in the central nervous system.
Collybistin acts as a guanine nucleotide exchange factor (GEF) for the Rho family GTPase Cdc42, facilitating the exchange of GDP for GTP and thereby activating Cdc42. Activated Cdc42 is involved in actin cytoskeleton reorganization, which is necessary for the morphological changes required during synapse formation.
Clinical Significance[edit]
Mutations in the ARHGEF9 gene have been associated with several neurological disorders, including epilepsy, intellectual disability, and hyperekplexia. These mutations can lead to defects in synaptic inhibition, resulting in an imbalance between excitatory and inhibitory neurotransmission in the brain.
For example, specific mutations in ARHGEF9 have been linked to X-linked intellectual disability and epilepsy, highlighting the importance of collybistin in normal cognitive and neurological function. The disruption of collybistin-gephyrin interactions due to these mutations can impair the clustering of inhibitory receptors, leading to increased neuronal excitability and seizure susceptibility.
Research[edit]
Ongoing research is focused on understanding the precise molecular mechanisms by which ARHGEF9 mutations lead to neurological disorders. Studies are also exploring potential therapeutic strategies to correct or compensate for the synaptic defects caused by these mutations.
Evolution[edit]
The ARHGEF9 gene is conserved across several species, indicating its fundamental role in synaptic function. Comparative studies of ARHGEF9 orthologs in different organisms can provide insights into its evolutionary history and functional conservation.
Also see[edit]

